CD28 and non-small cell lung carcinoma: Furthermore, the majority of CD8+ TILs in NSCLC did not express CD-28 and therefore may be less responsive and less proliferative than T cells within TDLN following anti-PD-1 therapy (Kamphorst et al., 2017).